{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:42:45Z","timestamp":1790757765928,"version":"4.1.0"},"reference-count":49,"publisher":"Walter de Gruyter GmbH","issue":"5","license":[{"start":{"date-parts":[[2010,7,31]],"date-time":"2010-07-31T00:00:00Z","timestamp":1280534400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s00005-010-0094-x","type":"journal-article","created":{"date-parts":[[2010,7,31]],"date-time":"2010-07-31T18:34:36Z","timestamp":1280601276000},"page":"325-333","source":"Crossref","is-referenced-by-count":18,"title":["Autoimmune Versus Oligodendrogliopathy: The Pathogenesis of Multiple Sclerosis"],"prefix":"10.2478","volume":"58","author":[{"given":"Jin","family":"Nakahara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadakazu","family":"Aiso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2010,7,31]]},"reference":[{"key":"94_CR1","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ana.20016","volume":"55","author":"MH Barnett","year":"2004","unstructured":"Barnett MH, Prineas JW (2004) Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 55:458\u2013468","journal-title":"Ann Neurol"},{"key":"94_CR2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature08478","volume":"462","author":"I Bartholom\u00e4us","year":"2009","unstructured":"Bartholom\u00e4us I, Kawakami N, Odoardi F et al (2009) Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions. Nature 462:94\u201398","journal-title":"Nature"},{"key":"94_CR3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00401-009-0601-5","volume":"119","author":"M Bradl","year":"2010","unstructured":"Bradl M, Lassmann H (2010) Oligodendrocytes: biology and pathology. Acta Neuropathol 119:37\u201353","journal-title":"Acta Neuropathol"},{"key":"94_CR4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/ana.21311","volume":"63","author":"EC Breij","year":"2008","unstructured":"Breij EC, Brink BP, Veerhuis R et al (2008) Homogeneity of active demyelinating lesions in established multiple sclerosis. Ann Neurol 63:16\u201325","journal-title":"Ann Neurol"},{"key":"94_CR5","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/cne.21307","volume":"502","author":"DA Brown","year":"2007","unstructured":"Brown DA, Sawchenko PE (2007) Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis. J Comp Neurol 502:236\u2013260","journal-title":"J Comp Neurol"},{"key":"94_CR6","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1474-4422(09)70017-1","volume":"8","author":"RK Burt","year":"2009","unstructured":"Burt RK, Loh Y, Cohen B et al (2009) Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I\/II study. Lancet Neurol 8:244\u2013253","journal-title":"Lancet Neurol"},{"key":"94_CR7","doi-asserted-by":"crossref","first-page":"6404","DOI":"10.1523\/JNEUROSCI.20-17-06404.2000","volume":"20","author":"A Chang","year":"2000","unstructured":"Chang A, Nishiyama A, Peterson J et al (2000) NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci 20:6404\u20136412","journal-title":"J Neurosci"},{"key":"94_CR8","first-page":"554","volume":"41","author":"J Charcot","year":"1868","unstructured":"Charcot J (1868) Histologie de la scl\u00e9rose en plaque. Gazette des H\u00f4pitaux 41:554\u2013566","journal-title":"Gazette des H\u00f4pitaux"},{"key":"94_CR9","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1056\/NEJMoa0802670","volume":"359","author":"AJ Coles","year":"2008","unstructured":"Coles AJ, Compston DA, Selmaj KW et al (2008) Alemtuzumab vs. interferon beta-1a in early multiple sclerosis. N Engl J Med 359:1786\u20131801","journal-title":"N Engl J Med"},{"key":"94_CR10","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature01355","volume":"421","author":"DJ Cua","year":"2003","unstructured":"Cua DJ, Sherlock J, Chen Y et al (2003) Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421:744\u2013748","journal-title":"Nature"},{"key":"94_CR11","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/(SICI)1521-4141(199902)29:02<626::AID-IMMU626>3.0.CO;2-A","volume":"29","author":"HP Eugster","year":"1999","unstructured":"Eugster HP, Frei K, Bachmann R et al (1999) Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1. Eur J Immunol 29:626\u2013632","journal-title":"Eur J Immunol"},{"key":"94_CR12","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/eji.1830170909","volume":"17","author":"K Frei","year":"1987","unstructured":"Frei K, Siepl C, Groscurth P et al (1987) Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells. Eur J Immunol 17:1271\u20131278","journal-title":"Eur J Immunol"},{"key":"94_CR13","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.4049\/jimmunol.181.7.4648","volume":"181","author":"GC Furtado","year":"2008","unstructured":"Furtado GC, Marcondes MC, Latkowski JA et al (2008) Swift entry of myelin-specific T lymphocytes into the central nervous system in spontaneous autoimmune encephalomyelitis. J Immunol 181:4648\u20134655","journal-title":"J Immunol"},{"key":"94_CR14","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(02)12023-X","volume":"360","author":"HP Hartung","year":"2002","unstructured":"Hartung HP, Gonsette R, K\u00f6nig N et al (2002) Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial. Lancet 360:2018\u20132025","journal-title":"Lancet"},{"key":"94_CR15","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/ana.21800","volume":"66","author":"AP Henderson","year":"2009","unstructured":"Henderson AP, Barnett MH, Parratt JD et al (2009) Multiple sclerosis: distribution of inflammatory cells in newly forming lesions. Ann Neurol 66:739\u2013753","journal-title":"Ann Neurol"},{"key":"94_CR16","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1212\/WNL.45.7.1268","volume":"45","author":"KP Johnson","year":"1995","unstructured":"Johnson KP, Brooks BR, Cohen JA et al (1995) Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind, placebo-controlled trial. Neurology 45:1268\u20131276","journal-title":"Neurology"},{"key":"94_CR17","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1523\/JNEUROSCI.2615-05.2006","volume":"26","author":"MR Kotter","year":"2006","unstructured":"Kotter MR, Li WW, Zhao C et al (2006) Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J Neurosci 26:328\u2013332","journal-title":"J Neurosci"},{"key":"94_CR18","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/brain\/awn096","volume":"131","author":"T Kuhlmann","year":"2008","unstructured":"Kuhlmann T, Miron V, Cui Q et al (2008) Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 131:1749\u20131758","journal-title":"Brain"},{"key":"94_CR19","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1073\/pnas.86.16.6348","volume":"86","author":"AP Lieberman","year":"1989","unstructured":"Lieberman AP, Pitha PM, Shin HS et al (1989) Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc Natl Acad Sci USA 86:6348\u20136352","journal-title":"Proc Natl Acad Sci USA"},{"key":"94_CR20","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/ana.20182","volume":"56","author":"CF Lucchinett","year":"2004","unstructured":"Lucchinett CF, Bruck W, Lassmann H (2004) Evidence for pathogenic heterogeneity in multiple sclerosis. Ann Neurol 56:308","journal-title":"Ann Neurol"},{"key":"94_CR21","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","volume":"47","author":"C Lucchinetti","year":"2000","unstructured":"Lucchinetti C, Br\u00fcck W, Parisi J et al (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707\u2013717","journal-title":"Ann Neurol"},{"key":"94_CR22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s004150050066","volume":"244","author":"E Millefiorini","year":"1997","unstructured":"Millefiorini E, Gasperini C, Pozzilli C et al (1997) Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome. J Neurol 244:153\u2013159","journal-title":"J Neurol"},{"key":"94_CR23","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/00005072-200606000-00006","volume":"65","author":"J Nakahara","year":"2006","unstructured":"Nakahara J, Aiso S (2006) Fc receptor-positive cells in remyelinating multiple sclerosis lesions. J Neuropathol Exp Neurol 65:582\u2013591","journal-title":"J Neuropathol Exp Neurol"},{"key":"94_CR24","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1517\/14728220903307491","volume":"13","author":"J Nakahara","year":"2009","unstructured":"Nakahara J, Aiso S, Suzuki N (2009a) Factors that retard remyelination in multiple sclerosis with a focus on TIP30: a novel therapeutic target. Expert Opin Ther Targets 13:1375\u20131376","journal-title":"Expert Opin Ther Targets"},{"key":"94_CR25","first-page":"169","volume":"119","author":"J Nakahara","year":"2009","unstructured":"Nakahara J, Kanekura K, Nawa M et al (2009b) Abnormal expression of TIP30 and arrested nucleocytoplasmic transport within oligodendrocyte precursor cells in multiple sclerosis. J Clin Invest 119:169\u2013181","journal-title":"J Clin Invest"},{"key":"94_CR26","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.neuroscience.2009.12.040","volume":"166","author":"Y Pang","year":"2010","unstructured":"Pang Y, Campbell L, Zheng B et al (2010) Lipopolysaccharide-activated microglia induce death of oligodendrocyte progenitor cells and impede their development. Neuroscience 166:464\u2013475","journal-title":"Neuroscience"},{"key":"94_CR27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1084\/jem.111.1.119","volume":"111","author":"PY Paterson","year":"1960","unstructured":"Paterson PY (1960) Transfer of allergic encephalomyelitis in rats by means of lymph node cells. J Exp Med 111:119\u2013136","journal-title":"J Exp Med"},{"key":"94_CR28","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1056\/NEJMoa044397","volume":"354","author":"CH Polman","year":"2006","unstructured":"Polman CH, O\u2019Connor PW, Havrdova E et al (2006) A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 354:899\u2013910","journal-title":"N Engl J Med"},{"key":"94_CR29","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/ni.1716","volume":"10","author":"A Reboldi","year":"2009","unstructured":"Reboldi A, Coisne C, Baumjohann D et al (2009) C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol 10:514\u2013523","journal-title":"Nat Immunol"},{"key":"94_CR30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1084\/jem.58.1.39","volume":"58","author":"TM Rivers","year":"1933","unstructured":"Rivers TM, Sprunt DH, Berry GP (1933) Observations on attempts to produce acute disseminated encephalomyelitis in monkeys. J Exp Med 58:39\u201353","journal-title":"J Exp Med"},{"key":"94_CR31","first-page":"204","volume":"91","author":"E Roboz-Einstein","year":"1959","unstructured":"Roboz-Einstein E (1959) Allergic encephalomyelitis as an experimental model for multiple sclerosis. Calif Med 91:204\u2013206","journal-title":"Calif Med"},{"key":"94_CR32","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1212\/01.wnl.0000345662.05861.e4","volume":"72","author":"M Rodriguez","year":"2009","unstructured":"Rodriguez M, Warrington AE, Pease LR (2009) Human natural autoantibodies in the treatment of neurologic disease. Neurology 72:1269\u20131276","journal-title":"Neurology"},{"key":"94_CR33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s100720170011","volume":"22","author":"G Rosati","year":"2001","unstructured":"Rosati G (2001) The prevalence of multiple sclerosis in the world: an update. Neurol Sci 22:117\u2013139","journal-title":"Neurol Sci"},{"key":"94_CR34","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1084\/jem.172.4.1193","volume":"172","author":"NH Ruddle","year":"1990","unstructured":"Ruddle NH, Bergman CM, McGrath KM et al (1990) An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J Exp Med 172:1193\u20131200","journal-title":"J Exp Med"},{"key":"94_CR35","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa044396","volume":"354","author":"RA Rudick","year":"2006","unstructured":"Rudick RA, Stuart WH, Calabresi PA et al (2006) Natalizumab plus interferon beta-1a for relapsing multiple sclerosis. N Eng J Med 354:911\u2013923","journal-title":"N Eng J Med"},{"key":"94_CR36","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.autrev.2007.02.003","volume":"6","author":"W Schrempf","year":"2007","unstructured":"Schrempf W, Ziemssen T (2007) Glatiramer acetate: mechanisms of action in multiple sclerosis. Autimmun Rev 6:469\u2013475","journal-title":"Autimmun Rev"},{"key":"94_CR37","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1093\/brain\/121.12.2221","volume":"121","author":"N Scolding","year":"1998","unstructured":"Scolding N, Franklin R, Stevens S et al (1998) Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis. Brain 121:2221\u20132228","journal-title":"Brain"},{"key":"94_CR38","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.4049\/jimmunol.147.5.1522","volume":"147","author":"K Selmaj","year":"1991","unstructured":"Selmaj K, Raine CS, Farooq M et al (1991a) Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J Immunol 147:1522\u20131529","journal-title":"J Immunol"},{"key":"94_CR39","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/ana.410300510","volume":"30","author":"K Selmaj","year":"1991","unstructured":"Selmaj K, Raine CS, Cross AH (1991b) Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann Neurol 30:694\u2013700","journal-title":"Ann Neurol"},{"key":"94_CR40","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0165-5728(94)00139-F","volume":"56","author":"K Selmaj","year":"1995","unstructured":"Selmaj K, Papierz W, Glabi\u0144ski A et al (1995) Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I. J Neuroimmunol 56:135\u2013141","journal-title":"J Neuroimmunol"},{"key":"94_CR41","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/glia.20371","volume":"54","author":"A Setzu","year":"2006","unstructured":"Setzu A, Lathia JD, Zhao C et al (2006) Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells. Glia 54:297\u2013303","journal-title":"Glia"},{"key":"94_CR42","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1212\/WNL.57.10.1885","volume":"57","author":"NL Sicotte","year":"2001","unstructured":"Sicotte NL, Voskuhl RR (2001) Onset of multiple sclerosis associated with anti-TNF therapy. Neurology 57:1885\u20131888","journal-title":"Neurology"},{"key":"94_CR43","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/ana.20743","volume":"58","author":"S Sriram","year":"2005","unstructured":"Sriram S, Steiner I (2005) Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis. Ann Neurol 58:939\u2013945","journal-title":"Ann Neurol"},{"key":"94_CR44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ana.20913","volume":"60","author":"L Steinman","year":"2006","unstructured":"Steinman L, Zamvil SS (2006) How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann Neurol 60:12\u201321","journal-title":"Ann Neurol"},{"key":"94_CR45","doi-asserted-by":"crossref","unstructured":"The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS\/MRI Analysis Group (1999) TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. Neurology 53:457\u2013465","DOI":"10.1212\/WNL.53.3.457"},{"key":"94_CR46","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2353\/ajpath.2008.070690","volume":"172","author":"JS Tzartos","year":"2008","unstructured":"Tzartos JS, Friese MA, Craner MJ et al (2008) Interleukin-17 production in central nervous system-infiltrating T cells and glial cells associated with active disease in multiple sclerosis. Am J Pathol 172:146\u2013155","journal-title":"Am J Pathol"},{"key":"94_CR47","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1212\/WNL.49.2.351","volume":"49","author":"BW Oosten van","year":"1997","unstructured":"van Oosten BW, Lai M, Hodgkinson S et al (1997) Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial. Neurology 49:351\u2013357","journal-title":"Neurology"},{"key":"94_CR48","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.3155574","volume":"227","author":"MK Waldor","year":"1985","unstructured":"Waldor MK, Sriram S, Hardy R et al (1985) Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker. Science 227:415\u2013417","journal-title":"Science"},{"key":"94_CR49","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1523\/JNEUROSCI.18-02-00601.1998","volume":"18","author":"G Wolswijk","year":"1998","unstructured":"Wolswijk G (1998) Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J Neurosci 18:601\u2013609","journal-title":"J Neurosci"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-010-0094-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00005-010-0094-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-010-0094-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T16:57:57Z","timestamp":1740329877000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00005-010-0094-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,31]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["94"],"URL":"https:\/\/doi.org\/10.1007\/s00005-010-0094-x","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"value":"0004-069X","type":"print"},{"value":"1661-4917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,31]]}}}